Italy· 038534044
BICALUTAMIDE DOC GENERICI
A bicalutamide product containing bicalutamide, registered in Italy by DOC GENERICI S.R.L., on the national reimbursement list. The same ATC class is registered in 18 of our 19 countries.
Checked against AIFA (Italy) on
Informational only — not a medical device.
Where it is registered
Bicalutamide is registered in 18 of 19 countries.
Countries holding a registration under ATC L02BB03 (bicalutamide), each read from that country’s own register.
- This record: Italy, from AIFA (Italy)
- 11 of them publish a price we can compare per daily dose
Bicalutamide · ATC L02BB03
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of bicalutamide costs, country by country.
Normalised to the WHO defined daily dose (50 mg), the median price runs from $1.21 in Italy to $2.29 in Switzerland — a ×1.9 gap.
- Italy: $1.21 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Bicalutamide · price per daily dose (50 mg)
USD · FX 28 Sept 2026
- CH Switzerland$2.29
- ES Spain$1.61
- FR France$1.42
- IT Italy$1.21
The record
At a glance
AIFA (Italy)- Active substance
- Bicalutamide
- Manufacturer
- DOC GENERICI S.R.L.
- Country
- Italy (IT)
- ATC code
- L02BB03
- ATC class
- Bicalutamide
- Defined daily dose
- 50 mg, O
- Reimbursed
- Yes
- Source register
- AIFA (Italy)
- Last checked
- September 28, 2026
Packs & prices · 1
1 priced- aic038534044"50 MG COMPRESSE RIVESTITE CON FILM" 28 COMPRESSE IN BLISTER PVC/PVDC/ALEUR 29.83
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
477 interactions on record for bicalutamide.
Graded by severity as the source publishes them — 82 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Bicalutamide · interactions on record
477 records
- 82 severe
- 302 moderate
- 15 minor
- 78 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- LonafarnibA16AX20severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Bicalutamide in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandBicalutamid ActavisActavis Group PTC ehf
- CzechiaBICALUPLEXTeva Pharmaceuticals CR, s.r.o., Praha
- SpainBICALUTAMIDA ACCORD 50 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFGAccord Healthcare S.L.U.
- FranceBICALUTAMIDE ACCORD 50 mg, comprimé pelliculéACCORD HEALTHCARE FRANCE
- BelgiumBicalutamide Accord Healthcare 50 mgAccord Healthcare
- SwedenBicalustad 50 mg Filmdragerad tablettSTADA Arzneimittel AG
- NetherlandsBicalutamide 50 PCH, filmomhulde tabletten 50 mgPharmachemie B.V.
- IrelandBicalutamide 50 mg film-coated tabletsAccord Healthcare Ireland Ltd.
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Androbloc, Bicalutamid +pharma
- Belgium · Bicalutamide Eg, Bicalutamide Sandoz
- Bulgaria · Бикагратис, Бикалутамид Акорд
- Cyprus · Bicalutamide Rafarm, Bikalen
- Czechia · Bicaluplex, Bicalutanorm
- Germany · Bicadex, Bicalut
- Denmark · Bicalustad, Bicalutamid Bluefish
- Estonia · Bicalutamide Accord, Bicalutamide Teva
- Spain · Bicalutamida Accord, Bicalutamida Almus
- Finland · Bicalutamid Orion, Bicalutamide Accord
- France · Bicalutamide Accord, Bicalutamide Almus
- United Kingdom (Northern Ireland) · Bicalutamide, Bicalutamide Accord Healthcare
- Greece · Bicalut, Bicalutamide Rafarm
- Croatia · Bicaprox, Bikalis
- Hungary · Bicalutamide Pharmacenter, Bilutamid
- Ireland · Bicalutamide Accord, Bicalutamide Fair-Med
- Iceland · Bicalutamid Medical, Bicalutamide Accord
- Lithuania · Bicalutamide Accord, Bicalutamide Teva
- Luxembourg · Bicalutamide Eg, Bicalutamide Teva
- Latvia · Bicalutamide Accord, Bicalutamide Teva
- Malta · Bicalutamide Pharmacare
- Netherlands · Bicalutamide Accord, Bicalutamide Aurobindo
- Norway · Bicalutamide Accord, Bicalutamide Bluefish
- Poland · Bicalutamide Accord, Binabic
- Portugal · Bicalutamida Accord, Bicalutamida Aurobindo
- Romania · Bicalutamida Accord, Bicalutamidă Accord
- Sweden · Bicalustad, Bicalutamid Sandoz
- Slovenia · Bikalutamid Accord, Bikalutamid Lek
- Slovakia · Bicagelan, Bicalutamid Teva
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AIFA (Italy). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c5c7b77c-d2a8-43c0-a6cf-4736b05c4983 GET /v1/drugs/c5c7b77c-d2a8-43c0-a6cf-4736b05c4983?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pack": "\"50 MG COMPRESSE RIVESTITE CON FILM\" 28 COMPRESSE IN BLISTER PVC/PVDC/AL",
"source": "aifa",
"currency": "EUR",
"substance": "Bicalutamide",
"reference_pack": "28 UNITA' 50 MG - USO ORALE",
"public_price_eur": 29.83,
"ssn_reference_price_eur": 29.83
}See everything about bicalutamide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.